NASDAQ:STXS

Stereotaxis Stock Insider Trading

Healthcare > Medical - Instruments & Supplies

Buy STXS

*Your capital is at risk

$1.84

-0.130 (-6.60%)

At Close: Jun 03, 2026

Stereotaxis Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 3.37M and sold 0 STXS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	3.37M shares
● Sell	0 shares
100% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 07, 2025 Buy	Common stock P-Purchase	Isaac Paul J See Remarks	Director	1 489 Value: $3K
Mar 07, 2025 Buy	Common stock P-Purchase	Isaac Paul J See Remarks	Director	1 489 Value: $3K
Mar 06, 2025 Buy	Common stock P-Purchase	Isaac Paul J See Remarks	Director	23 299 Value: $42.2K
Mar 06, 2025 Buy	Common stock P-Purchase	Isaac Paul J See Remarks	Director	23 299 Value: $42.2K
Jan 02, 2025 Buy	Common Stock A-Award	Levin Ross B Director	Director	56 497 Value: $129.4K
Jan 02, 2025 Buy	Common Stock A-Award	Menawat Arun Swarup Director	Director	56 497 Value: $129.4K
Jan 02, 2025 Buy	Common Stock A-Award	Fischel Nathan	Director	56 497 Value: $129.4K
Jan 02, 2025 Buy	Common Stock A-Award	Benfer David Director	Director	56 497 Value: $129.4K
Jan 02, 2025 Buy	Common Stock A-Award	Curet Myriam Director	Director	56 497 Value: $129.4K
Jan 02, 2025 Buy	Common Stock A-Award	Shamir Nachum Director	Director	45 608 Value: $104.4K
Jan 02, 2025 Buy	Common Stock A-Award	Shamir Nachum Director	Director	45 608 Value: $104.4K
Jan 02, 2025 Buy	Common Stock A-Award	Curet Myriam Director	Director	56 497 Value: $129.4K
Jan 02, 2025 Buy	Common Stock A-Award	Benfer David Director	Director	56 497 Value: $129.4K
Jan 02, 2025 Buy	Common Stock A-Award	Fischel Nathan	Director	56 497 Value: $129.4K
Jan 02, 2025 Buy	Common Stock A-Award	Menawat Arun Swarup Director	Director	56 497 Value: $129.4K
Jan 02, 2025 Buy	Common Stock A-Award	Levin Ross B Director	Director	56 497 Value: $129.4K
Aug 20, 2024 Buy	Common stock P-Purchase	Isaac Paul J See Remarks	Director	442 Value: $831
Aug 20, 2024 Buy	Common stock P-Purchase	Isaac Paul J See Remarks	Director	442 Value: $831
Aug 19, 2024 Buy	Common stock P-Purchase	Isaac Paul J See Remarks	Director	812 Value: $2K
Aug 19, 2024 Buy	Common stock P-Purchase	Isaac Paul J See Remarks	Director	812 Value: $2K
Aug 15, 2024 Buy	Common stock P-Purchase	Isaac Paul J See Remarks	Director	8 095 Value: $15.3K
Aug 15, 2024 Buy	Common stock P-Purchase	Isaac Paul J See Remarks	Director	8 095 Value: $15.3K
Jul 18, 2024 Buy	Common Stock J-Other	Shamir Nachum	Director	0 Value: $0
Jul 18, 2024 Buy	Common Stock J-Other	Shamir Nachum	Director	0 Value: $0
Jul 01, 2024 Buy	Common Stock A-Award	Levin Ross B Director	Director	53 475 Value: $94.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT STEREOTAXIS

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the...

Read Full Profile Here